Skip to main content
Genome Announcements logoLink to Genome Announcements
. 2015 Aug 13;3(4):e00882-15. doi: 10.1128/genomeA.00882-15

Complete Genome Sequences of Low-Passage Virulent and High-Passage Avirulent Variants of Pathogenic Leptospira interrogans Serovar Manilae Strain UP-MMC-NIID, Originally Isolated from a Patient with Severe Leptospirosis, Determined Using PacBio Single-Molecule Real-Time Technology

Kazuhito Satou a,, Makiko Shimoji a, Hinako Tamotsu a, Ayaka Juan a, Noriko Ashimine a, Misuzu Shinzato a, Claudia Toma b, Toshitsugu Nohara b, Akino Shiroma a, Kazuma Nakano a, Kuniko Teruya a, Yasunobu Terabayashi a, Shun Ohki a, Nobuo Koizumi c, Shou Okano d, Toshihiko Suzuki b, Takashi Hirano a
PMCID: PMC4536678  PMID: 26272567

Abstract

Here, we report the complete genome sequences of low-passage virulent and high-passage avirulent variants of pathogenic Leptospira interrogans serovar Manilae strain UP-MMC-NIID, a major causative agent of leptospirosis. While there were no major differences between the genome sequences, the levels of base modifications were higher in the avirulent variant.

GENOME ANNOUNCEMENT

Leptospira interrogans is a highly motile, obligate aerobic spirochaete that causes leptospirosis in both humans and animals, including wildlife, livestock, and pets (1). Leptospirosis is one of the most widespread (re)emerging zoonoses in the world, particularly in tropical and subtropical regions (2); it is both a neglected zoonotic disease (NZD) (3) and a neglected tropical disease (NTD) (4). L. interrogans colonizes the kidneys of reservoirs (e.g., rodents) and is shed in urine. Humans and animals become infected through environmental, occupational, or recreational activities involving contact with the urine or contaminated water or soil (5). Recently, in Okinawa, the southernmost prefecture in Japan, outbreaks have been reported among tourists enjoying water sports after heavy rainfall (6) and among American Marines attending jungle warfare training (7).

The pathogenic mechanisms of L. interrogans remain poorly understood; however, we have previously shown that virulence is correlated with increased phagocytic uptake and survival within macrophages (8) and two outer membrane proteins upregulated in the virulent variant enhance phagocytosis (9).

To date, complete genome sequences of L. interrogans are publicly available for five strains of four serovars (http://www.ncbi.nlm.nih.gov/genome/genomes/179). They consist of two circular chromosome genomes (around 4.3 Mb long with 35.0% G+C content and around 364.9 kb long with 35.0% G+C content) (1015) and up to three plasmid genomes (around 64.1 kb long with 35.4% G+C content) (13, 14, 16). In this study, we performed whole-genome sequencing and de novo assembly of virulent and avirulent variants of L. interrogans to elucidate the pathogenomic mechanisms underlying leptospirosis.

L. interrogans serovar Manilae strain UP-MMC-NIID examined in this study had originally been isolated from the blood of a patient with severe leptospirosis (17, 18). The virulent and avirulent variants were derived by serial subculture after 1 (low) and 67 (high) passages, respectively (9). For each variant, extracted DNA was sheared to 20-kb fragments using g-TUBE (Covaris, Woburn, MA, USA) and converted into 20-kb template libraries. Whole-genome sequencing was carried out using the PacBio RS II platform (Pacific Biosciences, Menlo Park, CA, USA) with P5-C3 chemistry and 180-min movies. De novo assembly was conducted using the Hierarchical Genome Assembly Process (HGAP) (19) workflow involving consensus polishing with Quiver. This workflow constructed three single self-overlapping contigs representing two chromosomes and one plasmid for each variant. Annotation was added by the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) (20). DNA base modification detection was also carried out using the kinetics data collected during the sequencing process. A summary of the genome statistics for both variants is shown in Table 1.

TABLE 1 .

Summary of the genome statistics for low-passage virulent and high-passage avirulent variants of pathogenic L. interrogans serovar Manilae strain UP-MMC-NIID

No. of passages Variant type Replicon name Coverage depth (fold) Genome size (bp) G+C content (%) No. of genes No. of CDSsa Accession no.
1 (low passage) Virulent Chromosome 1 501 4,238,972 35.00 3,562 3,431 CP011931
Chromosome 2 413 358,378 34.91 298 294 CP011932
Plasmid pLIMLP1 149 70,055 34.54 69 65 CP011933
67 (high passage) Avirulent Chromosome 1 533 4,238,922 35.00 3,561 3,422 CP011934
Chromosome 2 405 358,377 34.91 300 295 CP011935
Plasmid pLIMHP1 208 70,055 34.54 69 65 CP011936
a

CDSs, coding sequences.

We found that while there were no major differences between the genome sequences, the levels of base modifications such as methylation were higher in the avirulent variant. These findings support the differential expression of hundreds of proteins between the strains demonstrated in our previous study (9). In addition, we discovered a novel plasmid in the pathogenic species.

Nucleotide sequence accession numbers.

The complete genome sequences of both variants are available in DDBJ/ENA/GenBank under the accession numbers listed in Table 1.

ACKNOWLEDGMENT

This work was supported by the Okinawa Prefectural Government.

Footnotes

Citation Satou K, Shimoji M, Tamotsu H, Juan A, Ashimine N, Shinzato M, Toma C, Nohara T, Shiroma A, Nakano K, Teruya K, Terabayashi Y, Ohki S, Koizumi N, Okano S, Suzuki T, Hirano T. 2015. Complete genome sequences of low-passage virulent and high-passage avirulent variants of pathogenic Leptospira interrogans serovar Manilae strain UP-MMC-NIID, originally isolated from a patient with severe leptospirosis, determined using PacBio single-molecule real-time technology. Genome Announc 3(4):e00882-15. doi:10.1128/genomeA.00882-15.

REFERENCES

  • 1.WHO 2003. Human leptospirosis: guidance for diagnosis, surveillance and control. World Health Organization, Geneva, Switzerland: http://whqlibdoc.who.int/hq/2003/WHO_CDS_CSR_EPH_2002.23.pdf?ua=1. [Google Scholar]
  • 2.WHO 1999. Leptospirosis worldwide, 1999. Wkly Epidemiol Rec 74:237–244. http://www.who.int/docstore/wer/pdf/1999/wer7429.pdf. [PubMed] [Google Scholar]
  • 3.WHO 2011. The control of neglected zoonotic diseases: community-based interventions for prevention and control. World Health Organization, Geneva, Switzerland: http://whqlibdoc.who.int/publications/2011/9789241502528_eng.pdf. [Google Scholar]
  • 4.WHO 2009. Neglected tropical diseases, hidden successes, emerging opportunities. World Health Organization, Geneva, Switzerland: http://whqlibdoc.who.int/publications/2009/9789241598705_eng.pdf. [Google Scholar]
  • 5.Wasiński B, Dutkiewicz J. 2013. Leptospirosis—current risk factors connected with human activity and the environment. Ann Agric Environ Med 20:239–244. [PubMed] [Google Scholar]
  • 6.Narita M, Fujitani S, Haake DA, Paterson DL. 2005. Leptospirosis after recreational exposure to water in the Yaeyama islands, Japan. Am J Trop Med Hyg 73:652–656. [PMC free article] [PubMed] [Google Scholar]
  • 7.Stewart J. 3 November 2014. Oki Marines fall ill after training in murky waters. Marine Corps Times. http://www.marinecorpstimes.com/story/military/pentagon/2014/11/03/oki-marines-fall-ill-after-training-in-murky-waters/18402307.
  • 8.Toma C, Okura N, Takayama C, Suzuki T. 2011. Characteristic features of intracellular pathogenic Leptospira in infected murine macrophages. Cell Microbiol 13:1783–1792. doi: 10.1111/j.1462-5822.2011.01660.x. [DOI] [PubMed] [Google Scholar]
  • 9.Toma C, Murray GL, Nohara T, Mizuyama M, Koizumi N, Adler B, Suzuki T. 2014. Leptospiral outer membrane protein LMB216 is involved in enhancement of phagocytic uptake by macrophages. Cell Microbiol 16:1366–1377. doi: 10.1111/cmi.12296. [DOI] [PubMed] [Google Scholar]
  • 10.Ren SX, Fu G, Jiang XG, Zeng R, Miao YG, Xu H, Zhang YX, Xiong H, Lu G, Lu LF, Jiang HQ, Jia J, Tu YF, Jiang JX, Gu WY, Zhang YQ, Cai Z, Sheng HH, Yin HF, Zhang Y, Zhu GF, Wan M, Huang HL, Qian Z, Wang SY, Ma W, Yao ZJ, Shen Y, Qiang BQ, Xia QC, Guo XK, Danchin A, Saint Girons I, Somerville RL, Wen YM, Shi MH, Chen Z, Xu JG, Zhao GP. 2003. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 422:888–893. doi: 10.1038/nature01597. [DOI] [PubMed] [Google Scholar]
  • 11.Nascimento AL, Ko AI, Martins EA, Monteiro-Vitorello CB, Ho PL, Haake DA, Verjovski-Almeida S, Hartskeerl RA, Marques MV, Oliveira MC, Menck CF, Leite LC, Carrer H, Coutinho LL, Degrave WM, Dellagostin OA, El-Dorry H, Ferro ES, Ferro MI, Furlan LR, Gamberini M, Giglioti EA, Góes-Neto A, Goldman GH, Goldman MH, Harakava R, Jerônimo SM, Junqueira-de-Azevedo IL, Kimura ET, Kuramae EE, Lemos EG, Lemos MV, Marino CL, Nunes LR, de Oliveira RC, Pereira GG, Reis MS, Schriefer A, Siqueira WJ, Sommer P, Tsai SM, Simpson AJ, Ferro JA, Camargo LE, Kitajima JP, Setubal JC, Van Sluys MA. 2004. Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J Bacteriol 186:2164–2172. doi: 10.1128/JB.186.7.2164-2172.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Zhong Y, Chang X, Cao XJ, Zhang Y, Zheng H, Zhu Y, Cai C, Cui Z, Zhang Y, Li YY, Jiang XG, Zhao GP, Wang S, Li Y, Zeng R, Li X, Guo XK. 2011. Comparative proteogenomic analysis of the Leptospira interrogans virulence-attenuated strain IPAV against the pathogenic strain 56601. Cell Res 21:1210–1229. doi: 10.1038/cr.2011.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Huang L, Zhu W, He P, Zhang Y, Zhuang X, Zhao G, Guo X, Qin J, Zhu Y. 2014. Re-characterization of an extrachromosomal circular plasmid in the pathogenic Leptospira interrogans serovar Lai strain 56601. Acta Biochim Biophys Sin 46:605–611. doi: 10.1093/abbs/gmu033. [DOI] [PubMed] [Google Scholar]
  • 14.Zhu W, Wang J, Zhu Y, Tang B, Zhang Y, He P, Zhang Y, Liu B, Guo X, Zhao G, Qin J. 2015. Identification of three extra-chromosomal replicons in Leptospira pathogenic strain and development of new shuttle vectors. BMC Genomics 16:90. doi: 10.1186/s12864-015-1321-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Alt DP, Wilson-Welder JH, Bayles DO, Cameron C, Adler B, Bulach DM, Seemann T, Lehane MJ, Haines LR, Darby AC, Hall N, Radford AD, Zuerner RL. 2015. Complete genome sequence of Leptospira interrogans serovar Bratislava, strain PigK151. Genome Announc 3(3):e00678-15. doi: 10.1128/genomeA.00678-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zhu WN, Huang LL, Zeng LB, Zhuang XR, Chen CY, Wang YZ, Qin JH, Zhu YZ, Guo XK. 2014. Isolation and characterization of two novel plasmids from pathogenic Leptospira interrogans serogroup Canicola serovar Canicola strain Gui44. PLoS Negl Trop Dis 8:e3103. doi: 10.1371/journal.pntd.0003103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Koizumi N, Watanabe H. 2003. Identification of a novel antigen of pathogenic Leptospira spp. that reacted with convalescent mice sera. J Med Microbiol 52:585–589. doi: 10.1099/jmm.0.05148-0. [DOI] [PubMed] [Google Scholar]
  • 18.Koizumi N, Watanabe H. 2004. Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 22:1545–1552. doi: 10.1016/j.vaccine.2003.10.007. [DOI] [PubMed] [Google Scholar]
  • 19.Chin CS, Alexander DH, Marks P, Klammer AA, Drake J, Heiner C, Clum A, Copeland A, Huddleston J, Eichler EE, Turner SW, Korlach J. 2013. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods 10:563–569. doi: 10.1038/nmeth.2474. [DOI] [PubMed] [Google Scholar]
  • 20.Angiuoli SV, Gussman A, Klimke W, Cochrane G, Field D, Garrity G, Kodira CD, Kyrpides N, Madupu R, Markowitz V, Tatusova T, Thomson N, White O. 2008. Toward an online repository of standard operating procedures (SOPs) for (meta)genomic annotation. Omics 12:137–141. doi: 10.1089/omi.2008.0017. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genome Announcements are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES